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We present a novel surface plasmon resonance (SPR) biosensor for detection of human interferon gamma (hIFNJ), an important 
diagnostic marker for several infectious diseases. The biosensor employs engineered proteins derived from albumin binding 
domain (ABD) and selected with ribosome display to provide high affinity towards hIFNJ. We demonstrate that the biosensor 
provides rapid, sensitive, and cost-effective platform for the detection of K,)1Ȗ and allows its detection at nanomolar levels both 
in buffer and diluted human plasma. 
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1. Introduction 
Human interferon-gamma (K,)1Ȗ LV DQ LPSRUWDQW LQÀDmmatory cytokine [1] and its levels provide diagnostic 
information on various infectious diseases, including AIDS and tuberculosis. Secreted cytokines, such as hIFNJ, are 
commonly detected using antibody-based sandwich immunoassays. These conventional strategies, such as ELISA, 
can detect very low concentrations of K,)1Ȗ (~10 pg/mL), but they are time-consuming, require multiple steps, and 
involve enzymes and antibodies which are sometimes difficult to produce. As an alternative to natural antibodies 
[2], aptamers have been also used [3]. 
Protein engineering has become a powerful tool for generating proteins with desired properties for various 
applications, such as medicine and biotechnology (for review, see [4]). The engineered proteins stem from native 
proteins of small size, robust structure (scaffolds [5]) and natural recognition ability towards a specific analyte. 
Upon site-directed mutagenesis of several amino-acid residues, the binding site of the scaffold protein is 
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transformed to acquire affinity towards analyte of choice while losing the affinity towards the original binding 
partner at the same time. A large library of possible mutations can be screened using cell-dependent display systems, 
or cell-free display, such as ribosome display, or non-display systems [4], in order to select mutants exhibiting 
strong affinity towards the target molecule. Due to their small size and rigid structure, the selected scaffold proteins 
can be then easily synthesized de novo, reducing the cost and complexity of the bioreceptor production. 
In this work, we present an SPR biosensor for the detection of K,)1Ȗ using novel high-affinity engineered proteins 
derived from the albumin binding domain of protein G [6] and a competition assay format. It is demonstrated that 
the developed biosensor is able to detect K,)1Ȗ at concentrations down to nM both in buffer and diluted human 
plasma. 
2. Materials and methods 
2.1. Preparation of hIFNJ  
7KH K,)1Ȗ-AviTag was prepared using a synthetic gene coding for a 143 residue-long YDULDQW RI K,)1Ȗ with a C-
terminal AviTag consensus sequence (GLNDIFEAQKIEWHE). This was produced from the pET-28b vector as a C-
terminally biotinylated hIFN-Ȗ-AviTag protein in E.coli BL21 (DE3)BirA cells, upon induction with 1 mM IPTG in 
the presence 50 PM d-biotin (Sigma-Aldrich). hIFN-Ȗ-AviTag was extracted from inclusion bodies with 8 M urea in 
50 mM Tris buffer (pH7.4) and purified by a combination of chromatographies on SP Sepharose and Phenyl 
Sepharose CL-4B (GE Healthcare) at pH 7.4. The eluted hIFNȖ-AviTag protein was dialyzed into 50 mM 
ammonium acetate solution (pH 5.0).  
2.2. Construction and production of ABD20-AviTag 
The ABD20-AviTag proteins were constructed from the ABD20-TolA variant [6], in which the 306 residue-long 
TolA moiety was replaced by the AviTag sequence. The resulting 8.5 kD protein was produced in E.coli BL21 
(DE3)BirA cells as above, extracted from inclusion bodies with 8 M urea, 150 mM NaCl in 50 mM Tris buffer (pH 
8), purified by size exclusion chromatography and refolded by >100-fold dilution into the SPR running buffer.  
2.3. SPR instrument: 
In this work, we used a four-channel SPR system developed at the Institute of Photonics and Electronics AS CR, 
v.v.i., Prague, Czech Republic. The sensor is based on the attenuated total reflection method and wavelength 
spectroscopy of surface plasmons [7]. In this sensor, white light is used to excite surface plasmons on a thin gold 
film in four areas (sensing channels) which are interfaced with four separate chambers of a four-channel flow-cell. 
2.4. Immobilization of hIFNȖ-AviTag: 
7KH K,)1Ȗ-AviTag  was immobilized to the gold sensor surface using covalent attachment to the self-DVVHPEOHG Ȧ
carboxyalkylthiol-self-assembled monolayer (SAM). The procedure of SAM formation is described in detail in Ref 
[7]. After the activation of carboxylic groups, the hIFNȖ was flowed in the concentration of 5 μg/mL in SA buffer 
(10 mM sodium acetate, pH 5 at 25°C) until the saturation of the surface occurred. After short injection of buffer, 
the 500 μg/mL solution of BSA was introduced. The remaining carboxylic groups were deactivated with 5-minute 
injection of 1M ethanolamine–hydrochloride (pH 8.5).  
2.5. Affinity analysis and competition assay: 
To characterize the binding of biotinylated ABD20-AviTag [6] to the immobilized K,)1Ȗ-AviTag, several different 
concentrations were injected to both measuring and reference channels for 10 minutes. Then, the running buffer was 
injected again and the dissociation phase of the interaction was monitored for another 10 minutes. The obtained 
kinetic curves were fitted using the 1:1 Langmuir model in BiaEvaluation software.  
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The detection of hIFNȖ-AviTag was performed in running buffer RB (10 mM HEPES, 150 mM NaCl, 50 μM 
EDTA, 0.005% Surfactant P20, pH 7.4, 25°C) at a temperature of 25°C and a flow rate of  ȝOPLQ 7KH VROXWLRQV
of ABD20-AviTag variant at 100 nM concentration was spiked with hIF1Ȗ-AviTag at concentrations 0 – 200 nM 
and injected into the measuring channels. After 10 minutes, the sample was replaced with running buffer and the 
dissociation phase was monitored. The absolute sensor response after 3 minutes of dissociation was used as the 
sensor response to the given concentration. Each concentration was measured using at least 3 different SPR chips. 
3. Experimental 
In this work, we used an ABD20 variant as binder of K,)1Ȗ. An ABD20-AviTag protein of small size (8.5 kDa) was 
constructed, which had a C-terminal AviTag consensus sequence required for in vivo biotinylation and an N-
terminal Trp leader sequence enhancing production and stability of the ABD scaffold. We investigated the 
interaction between the ABD20-AviTag protein in solution and hIFNȖ-AviTag immobilized on the surface of the 
SPR sensor and found the affinity constant to be 1.1 ± 0.5 nM. This value is very close to Kd of 2.7 ± 0.3 nM of the 
ABD20-TolA protein carrying a longer C-terminal alpha-helical TolA moiety (306 residues), which was studied in 
our previous work under the same experimental conditions [6].   
 
         
 
Figure 1: Scheme of the competition assay for detection of hIFNJ. 
The free hIFNJ captures the ABD20-AviTag and prevents its 
binding to hIFNJ immobilized on the sensor surface. 
Figure 2: Sensor response to samples with different concentrations 
of hIFNJ and with the addition of 100 nM ABD20-AviTag. Higher 
concentration of hIFNJ resulted in lower sensor response. Arrows 
indicate injection of solutions 
 
The ABD20-AviTag was used in a competition assay, in which ABD20-AviTag at a fixed concentration (100 nM) 
was spiked with various concentrations of hIFNJ-AviTag and flowed over the SPR chip surface with covalently 
immobilized hIFNJ Figure . The hIFNJ present in the solution captures the free ABD20-AviTag and causes a 
decrease in sensor response compared to the channel with pure ABD20-AviTag. The sensor response to hIFNJ in 
buffer is shown in Figure 2. As follows from Fig.2, the sensor response to samples containing hIFNJ is lower than 
that obtained for the (blank) sample exposed to ABD20-AviTag in running buffer with no hIFNJ present and the 
decrease is proportional to the concentration of hIFNJ. 
Figure 3 displays the absolute sensor response registered 3 minutes after the end of the sample injection 
normalized to the sensor response of the blank sample for different concentrations of hIFNJ. The calibration curve is 
shown in red and was obtained by the least square fitting. The limit of detection (LOD), which is defined as the 
analyte concentration that results in the sensor response equal to 3 times the standard deviation of noise, was 
determined to be below 1 nM concentration. This LOD is lower than the LODs achieved using biosensors and 
antibodies or aptamers as receptors [2, 3]. 
Figure 4 demonstrates the sensor response to 22% human plasma in running buffer, which was spiked with 100 
nM ABD-AviTag and various concentrations of hIFNJ. As can be observed in Figure 4, shortly after the injection, 
the sensor response steeply increases, which is mainly due to a large refractive index change. At the end of the 
injection, the sensor response decreases again, but stays above the initial baseline, suggesting that there is significant 
ABD20-AviTag hIFN
hIFN   
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adsorption of plasma proteins to the surface of the sensor. The sensor response was registered 3 minutes after the 
end of the sample injection (inset of Figure 4). Despite the non-specific adsorption of plasma proteins, differences in 
absolute sensor response can be observed, which correlated well with the concentrations of hIFNJ. Even the lowest 
used concentration (10 nM) produced sensor response which was clearly different from the blank sample with no 
hIFNJ added
 
   
 
Figure 3: Calibration curve for IFNJ. Dashed line indicates the 
level of baseline noise, which determines the limit of detection. 
Figure 4: Temporal sensor response to hIFNJ in 22% plasma. Inset 
shows details of the dissociation phase.  
4. Conclusions 
We have developed a new biosensor based on surface plasmon resonance and scaffold of albumin binding domain 
(ABD) modified to bind human interferon gamma (hIFNJ). Using the competition detection scheme, the biosensor 
was demonstrated to detect hIFNJ at concentrations down to 1 nM in buffer and down to 10 nM in 22% plasma. 
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